Primecap Management CO Standard Biotools Inc. Transaction History

Primecap Management CO

  • $136 Billion
  • Q2 2024

A detailed history of Primecap Management CO transactions in Standard Biotools Inc. stock. As of the latest transaction made, Primecap Management CO holds 3,008,643 shares of LAB stock, worth $5.57 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,008,643
Previous 3,021,843 0.44%
Holding current value
$5.57 Million
Previous $8.19 Million 34.97%
% of portfolio
0.0%
Previous 0.01%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024
SELL
$1.65 - $2.92 $21,780 - $38,544
-13,200 Reduced 0.44%
3,008,643 $5.33 Million
Q1 2024

May 13, 2024
SELL
$1.87 - $2.78 $60,027 - $89,238
-32,100 Reduced 1.05%
3,021,843 $8.19 Million
Q4 2023

Feb 09, 2024
SELL
$1.59 - $2.73 $46,327 - $79,544
-29,137 Reduced 0.95%
3,053,943 $6.75 Million
Q3 2023

Nov 13, 2023
SELL
$1.9 - $3.05 $261,890 - $420,402
-137,837 Reduced 4.28%
3,083,080 $8.94 Million
Q2 2023

Aug 11, 2023
SELL
$1.47 - $2.56 $1.88 Million - $3.27 Million
-1,276,656 Reduced 28.39%
3,220,917 $6.22 Million
Q1 2023

May 15, 2023
SELL
$1.3 - $2.24 $154,830 - $266,784
-119,100 Reduced 2.58%
4,497,573 $8.77 Million
Q4 2022

Feb 13, 2023
SELL
$0.93 - $1.52 $288,365 - $471,306
-310,070 Reduced 6.29%
4,616,673 $5.4 Million
Q3 2022

Nov 14, 2022
SELL
$1.1 - $2.06 $31,460 - $58,916
-28,600 Reduced 0.58%
4,926,743 $5.42 Million
Q2 2022

Aug 11, 2022
SELL
$1.6 - $3.99 $111,568 - $278,222
-69,730 Reduced 1.39%
4,955,343 $7.93 Million
Q1 2022

May 11, 2022
SELL
$2.8 - $3.96 $191,324 - $270,586
-68,330 Reduced 1.34%
5,025,073 $18 Million
Q4 2021

Feb 11, 2022
SELL
$3.63 - $6.13 $615,793 - $1.04 Million
-169,640 Reduced 3.22%
5,093,403 $20 Million
Q3 2021

Nov 12, 2021
SELL
$5.5 - $7.41 $435,105 - $586,205
-79,110 Reduced 1.48%
5,263,043 $34.7 Million
Q2 2021

Aug 10, 2021
SELL
$4.35 - $6.35 $341,866 - $499,046
-78,590 Reduced 1.45%
5,342,153 $32.9 Million
Q1 2021

May 14, 2021
SELL
$3.94 - $7.09 $51,614 - $92,879
-13,100 Reduced 0.24%
5,420,743 $24.5 Million
Q4 2020

Feb 08, 2021
SELL
$5.45 - $8.65 $1.19 Million - $1.89 Million
-218,100 Reduced 3.86%
5,433,843 $32.6 Million
Q3 2020

Nov 13, 2020
SELL
$4.34 - $11.43 $1.53 Million - $4.02 Million
-351,500 Reduced 5.85%
5,651,943 $42 Million
Q2 2020

Aug 13, 2020
SELL
$1.85 - $5.29 $323,010 - $923,634
-174,600 Reduced 2.83%
6,003,443 $24.1 Million
Q1 2020

May 14, 2020
SELL
$1.24 - $4.35 $371,752 - $1.3 Million
-299,800 Reduced 4.63%
6,178,043 $15.7 Million
Q4 2019

Feb 14, 2020
SELL
$2.3 - $5.12 $35,190 - $78,336
-15,300 Reduced 0.24%
6,477,843 $22.5 Million
Q3 2019

Nov 13, 2019
SELL
$4.63 - $12.15 $399,106 - $1.05 Million
-86,200 Reduced 1.31%
6,493,143 $30.1 Million
Q2 2019

Aug 14, 2019
SELL
$11.49 - $14.17 $24,129 - $29,757
-2,100 Reduced 0.03%
6,579,343 $81.1 Million
Q1 2019

May 14, 2019
SELL
$8.47 - $14.36 $758,912 - $1.29 Million
-89,600 Reduced 1.34%
6,581,443 $87.5 Million
Q4 2018

Feb 12, 2019
BUY
$7.18 - $8.83 $5.85 Million - $7.2 Million
815,000 Added 13.92%
6,671,043 $57.5 Million
Q3 2018

Nov 13, 2018
BUY
$5.92 - $8.35 $378,880 - $534,400
64,000 Added 1.1%
5,856,043 $43.9 Million
Q2 2018

Aug 13, 2018
BUY
$4.86 - $6.24 $24,300 - $31,200
5,000 Added 0.09%
5,792,043 $34.5 Million
Q1 2018

May 14, 2018
BUY
$5.75 - $7.97 $68,425 - $94,843
11,900 Added 0.21%
5,787,043 $33.8 Million
Q3 2017

Nov 13, 2017
BUY
$3.55 - $5.49 $20.5 Million - $31.7 Million
5,775,143
5,775,143 $29.1 Million

Others Institutions Holding LAB

# of Institutions
148
Shares Held
270M
Call Options Held
422K
Put Options Held
40.7K
View Full List

About STANDARD BIOTOOLS INC.

LAB Quotes by TradingView
  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $146M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email